Sugiyama Y[au] - Search Results

Year	Number of Results
1956	1
1957	2
1960	1
1961	1
1962	3
1964	6
1965	2
1966	3
1967	4
1968	6
1969	5
1970	4
1971	5
1972	11
1973	7
1974	9
1975	3
1976	3
1977	7
1978	11
1979	14
1980	20
1981	21
1982	37
1983	18
1984	40
1985	34
1986	34
1987	40
1988	45
1989	30
1990	35
1991	30
1992	39
1993	34
1994	42
1995	41
1996	54
1997	69
1998	62
1999	68
2000	53
2001	70
2002	74
2003	73
2004	60
2005	74
2006	68
2007	66
2008	74
2009	72
2010	82
2011	89
2012	94
2013	89
2014	64
2015	62
2016	85
2017	83
2018	103
2019	93
2020	92
2021	53

1

Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.

Saito Y, Muramatsu T, Kanai Y, Ojima H, Sukeda A, Hiraoka N, Arai E, Sugiyama Y, Matsuzaki J, Uchida R, Yoshikawa N, Furukawa R, Saito H. Saito Y, et al. Among authors: sugiyama y. Cell Rep. 2019 Apr 23;27(4):1265-1276.e4. doi: 10.1016/j.celrep.2019.03.088. Cell Rep. 2019. PMID: 31018139 Free article.

2

Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response.

Faraco G, Brea D, Garcia-Bonilla L, Wang G, Racchumi G, Chang H, Buendia I, Santisteban MM, Segarra SG, Koizumi K, Sugiyama Y, Murphy M, Voss H, Anrather J, Iadecola C. Faraco G, et al. Among authors: sugiyama y. Nat Neurosci. 2018 Feb;21(2):240-249. doi: 10.1038/s41593-017-0059-z. Epub 2018 Jan 15. Nat Neurosci. 2018. PMID: 29335605 Free PMC article.

3

Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease.

Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K, Almansour MA, Kikuchi JK, Taira M, Mitsui J, Takahashi Y, Ichikawa Y, Mano T, Iwata A, Harigaya Y, Matsukawa MK, Matsukawa T, Tanaka M, Shirota Y, Ohtomo R, Kowa H, Date H, Mitsue A, Hatsuta H, Morimoto S, Murayama S, Shiio Y, Saito Y, Mitsutake A, Kawai M, Sasaki T, Sugiyama Y, Hamada M, Ohtomo G, Terao Y, Nakazato Y, Takeda A, Sakiyama Y, Umeda-Kameyama Y, Shinmi J, Ogata K, Kohno Y, Lim SY, Tan AH, Shimizu J, Goto J, Nishino I, Toda T, Morishita S, Tsuji S. Ishiura H, et al. Among authors: sugiyama y. Nat Genet. 2019 Aug;51(8):1222-1232. doi: 10.1038/s41588-019-0458-z. Epub 2019 Jul 22. Nat Genet. 2019. PMID: 31332380

4

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma.

Gotoh O, Sugiyama Y, Takazawa Y, Kato K, Tanaka N, Omatsu K, Takeshima N, Nomura H, Hasegawa K, Fujiwara K, Taki M, Matsumura N, Noda T, Mori S. Gotoh O, et al. Among authors: sugiyama y. Nat Commun. 2019 Oct 31;10(1):4965. doi: 10.1038/s41467-019-12985-x. Nat Commun. 2019. PMID: 31672974 Free PMC article.

5

Physiologically-Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug-Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations.

Taskar KS, Pilla Reddy V, Burt H, Posada MM, Varma M, Zheng M, Ullah M, Emami Riedmaier A, Umehara KI, Snoeys J, Nakakariya M, Chu X, Beneton M, Chen Y, Huth F, Narayanan R, Mukherjee D, Dixit V, Sugiyama Y, Neuhoff S. Taskar KS, et al. Among authors: sugiyama y. Clin Pharmacol Ther. 2020 May;107(5):1082-1115. doi: 10.1002/cpt.1693. Epub 2019 Dec 31. Clin Pharmacol Ther. 2020. PMID: 31628859 Free PMC article. Review.

6

JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis　- Digest Version.

Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto SI, Yamashina A; Japanese Circulation Society Joint Working Group. Terasaki F, et al. Among authors: sugiyama y. Circ J. 2019 Oct 25;83(11):2329-2388. doi: 10.1253/circj.CJ-19-0508. Epub 2019 Oct 9. Circ J. 2019. PMID: 31597819 Free article. No abstract available.

7

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.

Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D, Yoshioka Y, Kobayashi K, Takase-Minegishi K, Watanabe T, Hamada N, Nagai H, Tsuchida N, Soejima Y, Nakano H, Kamiyama R, Uehara T, Kirino Y, Sekiguchi A, Ihata A, Ohno S, Nagaoka S, Nakajima H. Sugiyama Y, et al. Arthritis Res Ther. 2018 Jan 11;20(1):7. doi: 10.1186/s13075-017-1506-7. Arthritis Res Ther. 2018. PMID: 29325580 Free PMC article.

8

Phase 0/microdosing approaches: time for mainstream application in drug development?

Burt T, Young G, Lee W, Kusuhara H, Langer O, Rowland M, Sugiyama Y. Burt T, et al. Among authors: sugiyama y. Nat Rev Drug Discov. 2020 Nov;19(11):801-818. doi: 10.1038/s41573-020-0080-x. Epub 2020 Sep 8. Nat Rev Drug Discov. 2020. PMID: 32901140 Review.

9

TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis.

Kunishita Y, Yoshimi R, Kamiyama R, Kishimoto D, Yoshida K, Hashimoto E, Komiya T, Sakurai N, Sugiyama Y, Kirino Y, Ozato K, Nakajima H. Kunishita Y, et al. Among authors: sugiyama y. Front Immunol. 2020 Feb 7;11:98. doi: 10.3389/fimmu.2020.00098. eCollection 2020. Front Immunol. 2020. PMID: 32117252 Free PMC article.

10

Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug-Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects.

Asaumi R, Toshimoto K, Tobe Y, Hashizume K, Nunoya KI, Imawaka H, Lee W, Sugiyama Y. Asaumi R, et al. Among authors: sugiyama y. CPT Pharmacometrics Syst Pharmacol. 2018 Mar;7(3):186-196. doi: 10.1002/psp4.12275. Epub 2018 Feb 5. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 29368402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results